Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF
Publication
, Journal Article
Van Diepen, S; Hellkamp, AS; Patel, MR; Becker, RC; Breithardt, G; Halperin, JL; Hankey, GJ; Nessel, CC; Singer, DE; Berkowitz, SD; Califf, RM ...
Published in: CIRCULATION
November 20, 2012
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
November 20, 2012
Volume
126
Issue
21
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Van Diepen, S., Hellkamp, A. S., Patel, M. R., Becker, R. C., Breithardt, G., Halperin, J. L., … Mahaffey, K. W. (2012). Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF. CIRCULATION, 126(21).
Van Diepen, Sean, Anne S. Hellkamp, Manesh R. Patel, Richard C. Becker, Gunter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, et al. “Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF.” CIRCULATION 126, no. 21 (November 20, 2012).
Van Diepen S, Hellkamp AS, Patel MR, Becker RC, Breithardt G, Halperin JL, et al. Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF. CIRCULATION. 2012 Nov 20;126(21).
Van Diepen, Sean, et al. “Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF.” CIRCULATION, vol. 126, no. 21, LIPPINCOTT WILLIAMS & WILKINS, Nov. 2012.
Van Diepen S, Hellkamp AS, Patel MR, Becker RC, Breithardt G, Halperin JL, Hankey GJ, Nessel CC, Singer DE, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW. Rivaroxaban is Associated with a Reduced Risk of Thromboembolic events and Hemorrhagic Stroke in Patient with Heart Failure: Insights from ROCKET AF. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2012 Nov 20;126(21).
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
November 20, 2012
Volume
126
Issue
21
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology